RNF165
Disease associated variation - GWASdb
ChrPosSNP ID(dbSNP 142)RefAltOri SNP IDP-valueDrug NameDrug AnnoGWAS TraitHPO IDDO IDAATypeTrait or Drug
1843945004rs11663834TGrs116638346.39E-06ALPHA-TOCOPHEROLBETA CAROTENE|BETA-CAROTENE 15,15'-MONOOXYGENASE|BCMO1 PROTEIN, HUMAN|CAROTENOIDSCarotenoid and tocopherol levelsHPOID:0100514|HPOID:0008372DOID:10257|DOID:4026GintronGWASdb_drug
1843947216rs11874989CTrs118749898.06E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_drug
1843948347rs6507699CTrs65076991.24E-04GEMCITABINE|CYTARABINEMANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINEResponse to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_drug
1843945004rs11663834TGrs116638346.39E-06Carotenoid and tocopherol levelsHPOID:0100514|HPOID:0008372DOID:10257|DOID:4026GintronGWASdb_trait
1843947216rs11874989CTrs118749898.43E-05Lung adenocarcinomaHPOID:0100526DOID:3910CintronGWASdb_trait
1843947216rs11874989CTrs118749898.06E-04Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_trait
1843948347rs6507699CTrs65076991.24E-04Response to cytadine analogues (cytosine arabinoside)HPOID:0002664DOID:162CintronGWASdb_trait
1843959703rs3894151CTrs38941515.56E-04White matter integrityHPOID:0002500DOID:3312|DOID:936A,GintronGWASdb_trait
1843962917rs6507701TCrs65077018.60E-04EndometriosisHPOID:0000130DOID:289CintronGWASdb_trait
1843981647rs7238416GArs72384163.38E-04Multiple complex diseasesHPOID:0000118NAGintronGWASdb_trait
1844002268rs12607419CArs126074194.33E-04Smoking cessationHPOID:0000707DOID:0050742AintronGWASdb_trait